5.31
price down icon1.85%   -0.10
pre-market  Vorhandelsmarkt:  5.37   0.06   +1.13%
loading

Finanzdaten der Artelo Biosciences Inc-Aktie (ARTL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
3.089
- 2.379 3.812 1.195
Interest Income/Expense
0.111
- - - -
Operating Income/Loss
-3.089
- -2.379 -3.812 -1.195
Nonoperating Income/Loss
-0.031
- 0.007 0.034 0.063
Income/Loss From Continuing Operations Before Tax
3.14%
-3.12
-3.221 -2.372 -15.87 -1.132
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
3.14%
-3.12
-3.221 -2.372 -15.87 -1.132
Net Income/Loss
3.14%
-3.12
-3.221 -2.372 -15.87 -1.132
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - -12.10 -
Diluted Average Shares
0.787
- 3.281 0.01 3.228
Diluted Earnings Per Share
-3.97
- -0.72 -1.17 -0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
Kapitalisierung:     |  Volumen (24h):